Naar inhoud
Rijksinstituut voor Volksgezondheid en Milieu

Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I-MOVE primary care multicentre study | RIVM

Jaar: 2022
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I-MOVE primary care multicentre study | RIVM